Rhea-AI Impact
Rhea-AI Sentiment
Rhea-AI Summary

Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) announced a private placement of up to 7.5 million units at $0.40 per unit, aiming to raise $3 million. Each unit comprises one common share and a half-share purchase warrant, with each whole warrant exercisable at $0.50 per share for 24 months. The company can accelerate the expiry of the warrants if the stock price exceeds $0.80 for five consecutive days. Proceeds will support growth and general corporate purposes. The offering targets accredited U.S. investors under Regulation D and non-U.S. investors under Regulation S, with an expected closing date of July 18, 2024, pending regulatory approvals.

  • Jones Soda Co. aims to raise $3 million through a private placement.
  • The offering includes units with shares and warrants, potentially increasing shareholder value.
  • Proceeds will support growth and general corporate purposes, indicating strategic investment.
  • The issuance of additional shares and warrants may lead to shareholder dilution.
  • Market conditions could affect the successful exercise of warrants, impacting potential gains.

VANCOUVER, BC, July 10, 2024 /PRNewswire/ -- Jones Soda Co. ("Jones Soda" or the "Company") (CSE: JSDA, QTCQB: JSDA) is pleased to announce a private placement of up to 7,500,000 units of the Company (the "Units") at a price of $0.40 per Unit, for aggregate gross proceeds of US$3 million (the "Offering").

Each Unit will be composed of: (i) one (1) common share in the capital of the Company (each, a "Common Share"); and (ii) one‐half (1/2) of one detachable share purchase warrant (each whole warrant, a "Warrant"). Each whole Warrant will be exercisable into one Common Share at a price of US$0.50 per share for a period of 24 months from the date of issuance, subject to the Company having the right at its option to accelerate the expiry date of the Warrants to the date that is 30 days following delivery of a notice of acceleration to holders of Warrants if at any time the closing price of the Common Shares on the OTCQB or other stock exchange or over-the-counter market in the United States or on the Canadian Securities Exchange (the "CSE") exceeds US$0.80 (for the purposes of the CSE, the equivalent in Canadian dollars based on the daily exchange rate published by the Bank of Canada) for a period of five (5) consecutive trading days (the "Warrant Exercise Period"). Each whole Warrant may be exercised anytime during the Warrant Exercise Period upon the voluntary election to exercise by the Warrant holder.

The Company intends to use the net proceeds of the Offering to support growth and for general corporate purposes.

The Units are being offered and sold in the Offering (i) to persons in the "United States" or to "U.S. persons" (as such terms are defined in Regulation S under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act")), who qualify as  accredited investors in reliance on Rule 506(b) of Regulation D under the U.S. Securities Act (the "U.S. Financing"), and (i) outside the United States to non-U.S. persons in reliance on Regulation S under the U.S. Securities Act. The portion of the Offering intended to be conducted outside of the United States is expected to include an offering to eligible investors in each of the Provinces and Territories of Canada except Quebec pursuant to the listed issuer financing exemption under Part 5A of National Instrument 45-106 - Prospectus Exemptions (the "LIFE Offering"). There is no minimum amount of Units to be issued pursuant to either the U.S. Financing or LIFE Offering but the Offering is for aggregate gross proceeds of $3M million.  None of the Common Shares, Warrants or Common Shares issuable upon the exercise of such Warrants will be subject to any hold period under Canadian securities laws, but all such securities will be considered restricted securities under the U.S. Securities Act.

The Company expects to close the Offering on or about July 18, 2024, and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory approvals including the approval of the CSE.

The Common Shares and Warrants being offering and sold in the Offering will not be registered under the U.S. Securities Act at the time of the Offering, however, such securities will include registration rights. None of the Common Shares, Warrants, or Common Shares issuable upon exercise of the Warrants may be offered or sold in the United States absent registration under the U.S. Securities Act and all applicable state securities laws or an applicable exemption from such registration requirements.

This news release shall not constitute an offer to sell, or a solicitation of an offer to buy, the Units in the United States, and shall not constitute an offer, solicitation or sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful. This news release is being issued pursuant to and in accordance with Rule 135c under the U.S. Securities Act.

About Jones Soda

Jones Soda Co.® (CSE: JSDA, OTCQB: JSDA) is a leading developer of sodas and cannabis-infused beverages known for their premium taste, unique flavors and unconventional brand personality. Launched in 1996 as the original craft soda brand, the Company today markets a diverse portfolio of sodas, mixers and wellness beverages under the Jones® Soda brand as well as a line of award-winning cannabis beverages and edibles leveraging Jones' trademark flavors under the Mary Jones brand. For more information, visit,, or

The CSE does not accept responsibility for the adequacy or accuracy of this release.


Cautionary Statements Regarding Forward‐Looking Information

This news release may contain forward‐looking information within the meaning of applicable securities legislation in both Canada and the United States, which reflect management's current expectations regarding future events. Such information includes, without limitation, information regarding the intended use of proceeds from the Offering. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward‐looking information is typically identified by words such as: "believe", "expect", "anticipate", "intend", "estimate", "postulate" and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward‐looking information provided by the Company is not a guarantee of future results or performance and that such forward‐looking information is based upon a number of estimates and assumptions of management in light of management's experience and perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances, as of the date of this news release including, without limitation, that the Company will be able to utilize the net proceeds of the Offering in the manner intended; that general business and economic conditions will not change in a material adverse manner; and assumptions regarding political and regulatory stability and stability in financial and capital markets.

Forward‐looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward‐looking statements. Such risks and other factors include, among others: the risk that the Company may not be able to use the proceeds of the Offering as intended; the state of the financial markets for the Company's securities; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; and other risks and factors that the Company is unaware of at this time.

The forward‐looking statements contained in this news release are made as of the date of this news release. The Company disclaims any intention or obligation to update or revise any forward‐ looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Cision View original content to download multimedia:

SOURCE Jones Soda


What is the total amount Jones Soda plans to raise in the offering?

Jones Soda plans to raise $3 million through the offering.

What does each unit in Jones Soda's offering consist of?

Each unit consists of one common share and a half-share purchase warrant.

At what price is each unit being offered in Jones Soda's private placement?

Each unit is being offered at $0.40.

How long are the warrants in Jones Soda's offering exercisable?

The warrants are exercisable for 24 months from the date of issuance.

What is the exercise price for the whole warrants in Jones Soda's offering?

The exercise price for the whole warrants is $0.50 per share.

When is the expected closing date for Jones Soda's offering?

The expected closing date for the offering is around July 18, 2024.

What regulatory approvals are required for Jones Soda's offering?

The offering is subject to necessary regulatory approvals, including from the Canadian Securities Exchange (CSE).

Who are the target investors for Jones Soda's offering?

The offering targets accredited U.S. investors under Regulation D and non-U.S. investors under Regulation S.

What is the potential impact on shareholders from Jones Soda's offering?

The issuance of additional shares and warrants may lead to shareholder dilution.

Jones Soda Co.


JSDA Rankings

JSDA Latest News

JSDA Stock Data

Soft Drink Manufacturing
United States of America